Issue 3/2019
Content (11 Articles)
Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity
Maria J. Pereira, Jan W. Eriksson
Sulfonylurea
Therapy in Practice
The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus
Shazia Hussain, Tahseen A. Chowdhury
Aminoglycoside
Review Article
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
Khalid Eljaaly, Aisha Alharbi, Samah Alshehri, Jessica K. Ortwine, Jason M. Pogue
Imipenem
Review Article
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel, Alyssa R. Golden, Sheryl Zelenitsky, Karyn Wiebe, Courtney K. Lawrence, Heather J. Adam, Temilolu Idowu, Ronald Domalaon, Frank Schweizer, Michael A. Zhanel, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Ayman Noreddin, Joseph P. Lynch III, James A. Karlowsky
Stroke
Review Article
Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice
Kayla M. Miller, Michael J. Brenner
Polycystic Kidney Disease
Adis Drug Evaluation
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
Hannah A. Blair
Eravacycline: A Review in Complicated Intra-Abdominal Infections
Lesley J. Scott